Genomic and proteomic approaches for the development of cell culture medium

• US 20040265880A1
• Filed: 05/10/2004
• Published: 12/30/2004
• Est. Priority Date: 05/09/2003
• Status: Abandoned Application

• Current Assignee: Sigma-Aldrich Company (Sigma-Aldrich Corporation)
• Original Assignee: Sigma-Aldrich Company (Sigma-Aldrich Corporation)
• Inventors: Aboytes, Kathryn A., Johnson, Terrell K., Fong, Danny, Donahue, Laurel M., Allison, Daniel W.
• Application Number:
  US10/842,649
• Publication Number:
  US 20040265880A1
• Time in Patent Office: Days
• US Class Current: 435/6.16
• CPC Class Codes: B01J 2219/00378 Piezoelectric or ink jet dispensers
• CPC Class Codes: B01J 2219/00385 Printing
• CPC Class Codes: B01J 2219/00387 Applications using probes
• CPC Class Codes: B01J 2219/00527 Sheets
• CPC Class Codes: B01J 2219/00641 the porous medium being continuous, e.g. porous oxide substrates
• CPC Class Codes: B01J 2219/00659 Two-dimensional arrays
• CPC Class Codes: B01J 2219/00722 Nucleotides
• CPC Class Codes: B01J 2219/00725 Peptides
• CPC Class Codes: B01J 2219/0074 Biological products
• CPC Class Codes: C12N 5/0018 Culture media for cell or tissue culture media for specific animal cell type C12N5/06
• CPC Class Codes: C12N 5/0037 Serum-free medium, which may still contain naturally-sourced components
• CPC Class Codes: C12Q 1/6837 using probe arrays or probe chips C12Q1/6874 takes precedence

Abstract

The present invention relates to a method for designing a cell culture medium adapted to support a cell line in a pre-defined manner. The method includes generating an expression profile of a cell line, identifying from the expression profile a set of biomolecules to evaluate for their effect on an end-point assay using the cell line, testing each biomolecule in the set for its effect in the endpoint assay, wherein each biomolecule that is determined to have a measurable effect in the end-point assay relative to a control, not containing the biomolecule, is considered a positive biomolecule and formulating a cell culture medium for the cell line by adding a positive biomolecule to a basal medium to form a modified medium, and determining whether the modified medium is sufficient to support the cell line in the pre-defined manner. Methods for identifying biomolecules for use in designing a cell culture medium adapted to support a cell line in a pre-defined manner, methods for preparing a serum-free cell culture medium that is sufficient to support a cell line and arrays for use in such methods are also provided.

Claims

1. A method for formulating a cell culture medium comprising:

detecting a sequence in a cell, the sequence being a nucleic acid sequence or an expressed amino acid sequence, and

formulating a cell culture medium to contain a molecule to modulate the detected sequence or its expression or to modulate a cellular process affected by the detected sequence or its expression.

3. The method of claim 1, the method further comprising forming the formulated culture medium.

2. A method for formulating a cell culture medium, said method comprising:

detecting a sequence in a cell, the sequence being a nucleic acid sequence or an expressed amino acid sequence;

determining whether a molecule modulates the sequence or its expression or modulates a cellular process affected by the sequence or its expression;

formulating a cell culture medium to contain a molecule to modulate the detected sequence or its expression or to modulate a cellular process affected by the detected sequence or its expression.

4. The method of claim 2, the method further comprising forming the formulated culture medium.

5. The method of claim 2, wherein the detected sequence is a mutant nucleic acid sequence.

6. The method of claim 2, wherein the detected sequence is RNA or a mutant RNA.

7. The method of claim 2, wherein the detected sequence is mRNA or mutant mRNA.

8. The method of claim 2, wherein the detected sequence is an expressed amino acid sequence.

9. The method of claim 2, wherein the sequence is detected using an array comprising a plurality of distinct biopolymers selected from the group consisting of antibodies, antibody fragments, polynucleotides, polynucleotide fragments, polypeptides, and polypeptide fragments.

10. The method of claim 9 wherein the distinct biopolymers are polynucleotides derived from a cell or complements to the polynucleotides derived from the cell.

11. The method of claim 2, wherein the detection of the nucleic acid sequence comprises isolating a nucleic acid sequence from a cell, amplifying the isolated nucleic acid sequence, and detecting the amplified nucleic acid sequence.

12. The method of claim 11 wherein the detected nucleic acid sequence encodes a polypeptide that affects a cellular process.

13. The method of claim 12 wherein the polypeptide is selected from the group consisting of intracellular receptors, cell-surface receptors, enzymes, growth factors, cytokines, interleukins, transcription factors, hormones, adhesion molecules, cadherins, and integrins.

14. The method of claim 11, wherein the nucleic acid sequence is a deoxyribozyme, a ribozyme, a micoRNA, or a nucleic acid analog.

15. The method of claim 2, wherein the sequence is an expressed amino acid sequence and the detection of this sequence comprises isolating the amino acid sequence with an antibody or fragment thereof.

16. The method of claim 15, wherein the antibody or antibody fragment specifically binds to a polypeptide selected from the group consisting of intracellular receptors, cell-surface receptors, enzymes, growth factors, cytokines, interleukins, transcription factors, hormones, adhesion molecules, cadherins, and integrins.

17. The method of claim 2, wherein the nucleic acid sequence is a deoxyribozyme, a ribozyme, a micoRNA, or a nucleic acid analog.

18. The method of claim 2, wherein the molecule is an expressed polypeptide affecting a cellular process selected from the group consisting of cell division, cell growth, cell proliferation, cell support, cell metabolism, and adhesion.

19. The method of claim 2, wherein said determination step comprises use of an assay selected from the group consisting of a cell growth or proliferation assay, an adhesion assay, a production assay, a post translational modification assay, a transfection assay, an apoptosis assay, a paracrine control assay, an RNA interfering assay, and an immortalization assay.

20. The method of claim 2 wherein the formulated culture medium contains less than 10% (v/v) of serum.

21. The method of claim 2, wherein the formulated culture medium is serum-free.

22. The method of claim 2, wherein the cell is derived from an organism selected from the group consisting of vertebrates, invertebrates, bacteria, plants, fungi and mammals.

23. The method of claim 22, wherein the bacteria are Archaebacteria or Eubacteria.

24. A formulated cell culture medium made by the method of claim 2.

25. A method for preparing a cell culture medium, said method comprising:

contacting a polynucleotide with an array comprising a plurality of biopolymers immobilized on the surface of the array, the polynucleotide being derived from a cell or the complement thereof;

detecting a bound pair formed between the polynucleotide and an immobilized biopolymer;

selecting a molecule for inclusion in a cell culture medium based on the members of the detected bound pair;

testing selected molecule to determine its effect on a cellular process of the cell; and

formulating a cell culture medium to include the selected molecule.

26. The method of claim 25, wherein the biopolymer is a nucleic acid and the bound pair is a hybridized nucleic acid pair.

28. The method of claim 25, wherein the candidate component is added to a serum-free medium.

29. A cell culture medium made by the method of claims 25.

27. A method for preparing a cell culture medium, said method comprising:

contacting a polypeptide with an array comprising a plurality of biopolymers immobilized on the surface of the array;

detecting a bound pair formed between the polypeptide and an immobilized biopolymer;

selecting a molecule for inclusion in a cell culture medium based on the members of the detected bound pair;

testing selected molecule to determine its effect on a cellular process of the cell; and

; and

formulating a cell culture medium to include the selected molecule.

30. An array comprising at least one nucleic acid of, but less than the entire genome of, a Chinese hamster cell, said nucleic acid being immobilized on the surface of the array.

31. The array of claim 30, wherein the at least one nucleic acid is a plurality of nucleic acids.

32. The array of claim 30, wherein the at least one nucleic acid is a polynucleotide selected from the group consisting of Chinese hamster cell polynucleotides encoding or regulating the expression of receptors, enzymes, cytokines, interleukins, transcription factors, hormones, adhesion molecules, cadherins, and integrins.

33. The array of claim 30, wherein the polynucleotide is selected from the group consisting of a deoxyribozyme, a ribozyme, a microRNA, and a nucleic acid analog.

34. The array of claim 32, further comprising nucleic acids of Chinese hamster housekeeping genes.

35. A method for designing a cell culture medium adapted to support a cell line in a pre-defined manner, which method comprises:

(a) generating an expression profile of a cell line;

(b) identifying from the expression profile a set of biomolecules to evaluate for their effect on an end-point assay using the cell line;

(c) testing each biomolecule in the set for its effect in the endpoint assay, wherein each biomolecule that is determined to have a measurable effect in the end-point assay relative to a control, not containing the biomolecule, is considered a positive biomolecule; and

(d) formulating a cell culture medium for the cell line by adding a positive biomolecule to a basal medium to form a modified medium, and determining whether the modified medium is sufficient to support the cell line in the pre-defined manner.

36. The method according to claim 35 further comprising repeating step (d) with additional positive biomolecules until the modified medium is able to support the cell line in the predefined manner.

37. A method according to claim 35 wherein the expression profile is generated on an array comprising a plurality of distinct biopolymers immobilized thereon.

38. A method according to claim 37 wherein the array is a microarray or a macroarray.

39. A method according to claim 37 wherein the distinct biopolymers are polynucleotide sequences that partially encode, or are complementary to polynucleotide sequences that partially encode, polypeptides of known function.

40. A method according to claim 39 wherein a plurality of polynucleotide probes derived from the cell line are contacted with the biopolymers immobilized on the array under hybridizing conditions.

41. A method according to claim 40 further comprising detecting those probes that hybridize to the biopolymers immobilized on the array.

42. A method according to claim 41 wherein the hybridization of each probe to a distinct biopolymer indicates that the cell line expresses a polypeptide partially encoded by the biopolymer.

43. A method according to claim 37 wherein the distinct biopolymers are selected from the group consisting of antibodies, antibody fragments, polypeptide fragments and combinations thereof.

44. A method according to claim 43 wherein a polypeptide sample derived from the cell line is contacted with the array, and those polypeptides that specifically bind to an antibody or antibody fragment are detected and provide the expression profile.

45. A method according to claim 35 wherein the expression profile is generated by:

(a) making primer sets for a plurality of biopolymers;

(b) using the primer sets to amplify polynucleotide sequences isolated from the cell line; and

(c) detecting each amplified sequence, wherein the amplification of a particular sequence confirms that the cell line expresses a polypeptide encoded by the amplified sequence.

46. A method according to claim 45 wherein the polynucleotide sequences isolated from the cell line are reverse transcribed prior to amplification with the primer sets.

47. A method according to claim 45 wherein the primer sets are designed based on polynucleotide sequences that encode polypeptides that participate in biologically significant cellular processes.

48. A method according to claim 47 wherein the polypeptide is selected from the group consisting of intracellular receptors, cell-surface receptors, enzymes, growth factors, cytokines, interleukins, transcription factors, hormones, adhesion molecules, cadherins, integrins, deoxyribozymes and ribozymes.

49. A method according to claim 35 wherein the expression profile is generated by:

(a) preparing a protein sample from the cell line and separating the sample in two dimensions; and

(b) using a plurality of antibodies to identify specific proteins that are expressed by the cell line, wherein the binding of an antibody to a protein confirms that the cell line expresses the protein recognized by the antibody.

50. A method according to claim 49 wherein the antibody or antibody fragment specifically binds to a polypeptide selected from the group consisting of intracellular receptors, cell-surface receptors, enzymes, growth factors, cytokines, interleukins, transcription factors, hormones, adhesion molecules, cadherins, and integrins.

51. A method according to claim 37 wherein the biopolymer encodes a portion of a polypeptide, is an antibody or antibody fragment that specifically binds to a polypeptide or is itself a fragment of a polypeptide that is selected from the group consisting of intracellular receptors, cell-surface receptors, enzymes, growth factors, cytokines, interleukins, transcription factors, hormones, adhesion molecules, cadherins, integrins, deoxyribozymes and ribozymes.

52. A method according to claim 35 wherein the biomolecule is a polypeptide in a cellular process selected from the group consisting of cell division, cell growth, cell metabolism and adhesion.

53. A method according to claim 35 wherein the biomolecule is a small molecule.

54. A method according to claim 35 wherein the endpoint assay is selected from the group consisting of a cell growth or proliferation assay, an adhesion assay, a production assay, a post translational modification assay, a transfection assay, an apoptosis assay, a paracrine control assay and an immortalization assay.

55. A method according to claim 35 wherein the modified medium that supports the cell line is a low serum medium.

56. A method according to claim 55 wherein the medium contains less than 10%(wt) serum.

57. A method according to claim 56 wherein the medium contains less than 7.5%(wt) serum.

58. A method according to claim 57 wherein the medium contains less than 5%(wt) serum.

59. A method according to claim 58 wherein the medium contains between 1%-3%(wt) serum.

60. A method according to claim 59 wherein the medium contains less than 1%(wt) serum.

61. A method according to claim 60 wherein the medium is serum-free.

62. A method according to claim 35 wherein the cell line is derived from an organism selected from the group consisting of vertebrates, invertebrates, bacteria, plants, fungi and mammals.

63. A method according to claim 62 wherein the cell line is derived from a mammal.

64. A method according to claim 35 wherein the cell line is an immortalized cell line or a primary cell line.

65. A method according to claim 35 wherein the cell line is adapted to grow in suspension or is adapted to grow when attached to a substrate surface.

66. A cell culture medium made by the process of claims 35, 37, 43, 44, 45 or 46.

69. A process according to claim 66 further comprising repeating step (f) with additional positive biomolecules until the modified medium is able to support the cell line.

67. A method for identifying biomolecules for use in designing a cell culture medium adapted to support a cell line in a pre-defined manner comprising:

(a) generating a pool of polynucleotide probes that are complementary to polynucleotide sequences that encode fragments of polypeptides expressed by a cell line;

(b) contacting the pool of polynucleotide probes under hybridizing conditions with at least one array comprising a plurality of biopolymers immobilized on the surface of the array, each biopolymer encoding a fragment of a distinct polypeptide that participates in a biologically significant cellular process;

(c) generating an expression profile by detecting each polynucleotide probe that hybridizes to each biopolymer; and

(d) selecting biomolecules, based on the expression profile, to be candidate components for a cell culture medium based on the function of the polypeptide partially encoded by the biopolymers to which a probe hybridizes.

70. A cell culture medium made by the method of claims 67, 68 or 69.

68. A method for preparing a serum-free cell culture medium that is sufficient to support a cell line, which method comprises:

(a) generating a pool of polynucleotide probes that are complementary to polynucleotide sequences that encode fragments of polypeptides expressed by a cell line;

(b) contacting the pool of polynucleotide probes under hybridizing conditions with at least one array comprising a plurality of biopolymers immobilized on the surface of the array, each biopolymer encoding a fragment of a distinct polypeptide that participates in a biologically significant cellular process;

(c) generating an expression profile by detecting each polynucleotide probe that hybridizes to each biopolymer;

(d) selecting biomolecules, based on the expression profile, to be candidate components for a serum-free medium based on the function of the polypeptide partially encoded by the biopolymers to which a probe hybridizes;

(e) testing each candidate component to determine its effect on growth and/or proliferation of the cell line, and designating those candidate components that increase growth and/or proliferation of the cell line as positive biomolecules; and

(f) adding a positive biomolecule to a serum-free basal medium and evaluating the growth and/or proliferation of the cell line in the modified medium.

71. An array for designing and/or optimizing cell culture medium, which comprises a pool of biopolymers immobilized on a surface of a substrate, each biopolymer selected from the group consisting of polynucleotides encoding fragments of distinct polypeptides that are participants in biologically significant cellular processes, antibodies or antibody fragments that specifically bind to polypeptides that are participants in biologically significant cellular processes and fragments of polypeptides that are participants in biologically significant cellular processes.

72. An array according to claim 71 wherein each biopolymer is a distinct polynucleotide and encodes a portion of a polypeptide selected from the group consisting of intracellular receptors, cell-surface receptors, enzymes, growth factors, cytokines, interleukins, transcription factors, hormones, adhesion proteins, cadherins, and integrins.

73. An array according to claim 72 wherein the polypeptide is a participant in a pathway selected from the group consisting of cell division, cell growth, cell metabolism and adhesion.

74. An array according to claim 71 wherein each biopolymer is a distinct antibody or antibody fragment that specifically binds to an epitope on a polypeptide selected from the group consisting of intracellular receptors, cell-surface receptors, enzymes, growth factors, cytokines, interleukins, transcription factors, hormones, adhesion proteins, cadherins, and integrins.

75. An array according to claim 74 wherein the polypeptide is a participant in a pathway selected from the group consisting of cell division, cell growth, cell metabolism and adhesion.

76. A method for designing or optimizing a cell culture medium comprising using the array of claim 71 to generate an expression profile from which candidate biomolecules are identified for further testing as components in the cell culture medium.

77. A cell culture medium made using the microarray according to claim 71.